home / stock / taro / taro news


TARO News and Press, Taro Pharmaceutical Industries Ltd.

Stock Information

Company Name: Taro Pharmaceutical Industries Ltd.
Stock Symbol: TARO
Market: NYSE
Website: taro.com

Menu

TARO TARO Quote TARO Short TARO News TARO Articles TARO Message Board
Get TARO Alerts

News, Short Squeeze, Breakout and More Instantly...

TARO - India-based Sun Pharmaceutical closes merger with Taro

2024-06-24 08:02:26 ET More on Taro Pharmaceutical Seeking Alpha’s Quant Rating on Taro Pharmaceutical Financial information for Taro Pharmaceutical Read the full article on Seeking Alpha For further details see: India-based Sun Pharmaceutical clos...

TARO - (TARO) Investment Analysis

2024-06-03 08:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

TARO - (TARO) Technical Data

2024-05-24 09:50:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

TARO - Taro shareholders approve go-private deal with Sun Pharma

2024-05-23 08:35:58 ET More on Taro Pharmaceutical Estée Lauder, Reckitt, Taro Pharma fall amid cancer risk in acne treatments Seeking Alpha’s Quant Rating on Taro Pharmaceutical Financial information for Taro Pharmaceutical Read the full articl...

TARO - Taro Shareholders Approve Merger with Sun Pharma

Taro Shareholders Approve Merger with Sun Pharma Canada NewsWire MUMBAI, India and NEW YORK , May 23, 2024 /CNW/ -- Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) (together with its subsidiar...

TARO - Taro Pharmaceutical GAAP EPS of $0.40 beats by $0.09, revenue of $164.94M beats by $8.88M

2024-05-20 17:25:49 ET More on Taro Pharmaceutical Estée Lauder, Reckitt, Taro Pharma fall amid cancer risk in acne treatments Seeking Alpha’s Quant Rating on Taro Pharmaceutical Historical earnings data for Taro Pharmaceutical Financial informati...

TARO - Taro Provides Results for Year Ended March 31, 2024

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) today provided unaudited financial results for the quarter and year ended March 31, 2024. Quarter ended March 31, 2024 Highlights ─ compared to March 31, 2023 Net sales of $...

TARO - Expected US Company Earnings on Monday, May 20th, 2024

Inpixon (INPXV) is expected to report for Q1 2024 Siebert Financial Corp. (SIEB) is expected to report for Q1 2024 Greenwave Technology Solutions Inc. (GWAV) is expected to report for Q1 2024 Bank Hapoalim B.M. ADR (BKHYY) is expected to report for Q1 2024 Gelesis Holdings, Inc. (...

TARO - Taro to Release Full Year Results on May 20, 2024

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for year ended March 31, 2024, after the close of market on Monday, May 20, 2024. The release will be accessible on Taro’s website at www.taro.com . About Taro ...

TARO - Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Taro Shareholders Vote "FOR" Taro Sun Pharma Merger

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) today announced that leading independent proxy advisory firms Institutional Shareholder Services (“ISS”) and Glass Lewis & Co. (“Glass Lewis”) have both recommend...

Next 10